ERBB2 and neoplasm: Similarly, patients with stroma-high tumor (low TSR) also displayed a worse prognosis in HER2-positive breast cancer, TNBC, and luminal-HER2-negative breast cancer (all P < 0.05, Fig. 4B-D).